MedTrace Logo

Database and Biobank of Patients With Hypersensitivity Pneumonitis

NCT05549635 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-12-22

No results posted yet for this study

Summary

Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data.

The database and biobank will be available for studies of HP, and can be directly compared to the main PFBIO cohort, which has recruited patients with Idiopathic pulmonary Fibrosis (IPF) since 2016.

Biomarkers will be assessed as diagnostic and prognostic. Further subtyping of HP, based on blood markers (including precipitins) will also be possible with the PFBIO-HP project.

Conditions

  • Hypersensitivity Pneumonitis

Sponsors & Collaborators

  • Nils Hoyer

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-18
Primary Completion
2024-12-31
Completion
2028-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05549635 on ClinicalTrials.gov